EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors

Fathimathul Farisha K, Rushdiya KK, Shahana K, Priyanka S, Sangeetha S, Adithya G, Haripriya S, Baskar L

International Journal of Pharmacy and Pharmaceutical Research · 2026 · 32 (2) · 261-272

DOI: 10.25166/ijppr.2026.32.2.30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacy and Pharmaceutical Research, 2026. Verfasst von Fathimathul Farisha K und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

K, F. F., KK, R., K, S., S, P., S, S., G, A., S, H., & L, B. (2026). Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors. International Journal of Pharmacy and Pharmaceutical Research, 32(2), 261-272. https://doi.org/10.25166/ijppr.2026.32.2.30

Vancouver

K FF, KK R, K S, S P, S S, G A, et al. Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors. International Journal of Pharmacy and Pharmaceutical Research. 2026;32(2):261-272. doi:10.25166/ijppr.2026.32.2.30

BibTeX
@article{K2026,
  author = {K, Fathimathul Farisha and KK, Rushdiya and K, Shahana and S, Priyanka and S, Sangeetha and G, Adithya and S, Haripriya and L, Baskar},
  title = {Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors},
  journal = {International Journal of Pharmacy and Pharmaceutical Research},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {261--272},
  doi = {10.25166/ijppr.2026.32.2.30}
}
Kostenlos starten →